Matches in Wikidata for { <http://www.wikidata.org/entity/Q91778417> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91778417 description "article scientifique publié en 2019" @default.
- Q91778417 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91778417 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91778417 description "scientific article published on 07 December 2019" @default.
- Q91778417 description "wetenschappelijk artikel" @default.
- Q91778417 description "наукова стаття, опублікована 7 грудня 2019" @default.
- Q91778417 name "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 name "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 type Item @default.
- Q91778417 label "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 label "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 prefLabel "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 prefLabel "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 P1433 Q91778417-B7C2518A-2E0C-4026-9571-A43D36BE7190 @default.
- Q91778417 P1476 Q91778417-C541E710-FF78-4F6F-A466-22798B1ACBDD @default.
- Q91778417 P2093 Q91778417-01855298-BE95-4450-9555-EC1E613D3E92 @default.
- Q91778417 P2093 Q91778417-01D65AB0-ABF1-4A7A-ABD4-146525B8FC90 @default.
- Q91778417 P2093 Q91778417-13A1A536-6C7A-40B5-A389-EE6705F32158 @default.
- Q91778417 P2093 Q91778417-2AE1B2B1-EA3E-4D6B-BE94-C26196D11B2C @default.
- Q91778417 P2093 Q91778417-58853E9B-6416-4E3A-801D-B0CB76C707A8 @default.
- Q91778417 P2093 Q91778417-63FC0861-FE90-492C-A2D0-1A60D2C048D5 @default.
- Q91778417 P2093 Q91778417-A443D98C-9C1C-4153-9C9B-5B8A2B5C3949 @default.
- Q91778417 P2093 Q91778417-FDFE36D0-3028-44D8-B033-025B96DBA74F @default.
- Q91778417 P31 Q91778417-0B0D1431-FA27-4976-BE4C-62F8C3CA65BF @default.
- Q91778417 P356 Q91778417-D38E408D-D1B8-4C09-ABE7-E18EA5839705 @default.
- Q91778417 P50 Q91778417-BF38E16D-EEC2-4A7F-8721-1E059FFD106A @default.
- Q91778417 P577 Q91778417-AC660AFF-C00F-4264-9658-E0D49926CE68 @default.
- Q91778417 P698 Q91778417-C127CCCA-D37C-4E8D-893A-D032D80FB0D2 @default.
- Q91778417 P356 S10620-019-05982-Z @default.
- Q91778417 P698 31813132 @default.
- Q91778417 P1433 Q15716711 @default.
- Q91778417 P1476 "Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center" @default.
- Q91778417 P2093 "Alain Bitton" @default.
- Q91778417 P2093 "Christine Verdon" @default.
- Q91778417 P2093 "Ernest Seidman" @default.
- Q91778417 P2093 "Gary Wild" @default.
- Q91778417 P2093 "Jason Reinglas" @default.
- Q91778417 P2093 "Lorant Gonczi" @default.
- Q91778417 P2093 "Talat Bessissow" @default.
- Q91778417 P2093 "Waqqas Afif" @default.
- Q91778417 P31 Q13442814 @default.
- Q91778417 P356 "10.1007/S10620-019-05982-Z" @default.
- Q91778417 P50 Q42264535 @default.
- Q91778417 P577 "2019-12-07T00:00:00Z" @default.
- Q91778417 P698 "31813132" @default.